- InterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications
- IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments
- IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*
- IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology
- IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024
More ▼
Key statistics
On Thursday, Immunoprecise Antibodies Ltd (IPA:NMQ) closed at 1.26, 34.04% above the 52 week low of 0.94 set on Dec 06, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.26 |
---|---|
High | 1.32 |
Low | 1.26 |
Bid | 1.22 |
Offer | 1.32 |
Previous close | 1.26 |
Average volume | 68.79k |
---|---|
Shares outstanding | 26.32m |
Free float | 22.74m |
P/E (TTM) | -- |
Market cap | 33.16m USD |
EPS (TTM) | -0.414 USD |
Data delayed at least 15 minutes, as of May 09 2024 21:00 BST.
More ▼